Bavarian Nordic on Tuesday announced the launch of clinical trials for its MVA-BN mpox vaccine for children ages 2 to 11. Participants will receive two doses of the vaccine.
More on Jynneos
https://geoffpain.substack.com/p/monkey-pox-jabbing-harms
More on Jynneos
https://geoffpain.substack.com/p/monkey-pox-jabbing-harms